Safety and Efficacy Study of MGuard Stent After a Heart Attack
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 433 participants.
Also called NCT01368471
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 433 participants
- Sponsor
- Registry
-
NCT01368471
-
- Other papers using this trial's data
- Efficacy of an Embolic Protection Stent as a Function of Delay to Reperfusion in ST-Segment Elevation Myocardial Infarction (from the MASTER Trial)
- Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial
- Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Poland, South Africa
- Registry status
- Completed
Technical summary
Registry record NCT01368471. Randomized; single masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of MGuard Stent After a Heart Attack
- Acronym
- MASTER
- Condition
- Myocardial Infarction
- Intervention (Device)
- MGuard
- Intervention (Device)
- Control BMS or DES
- Lead sponsor
- InspireMD
Record details
- Record id
cardio:ct-nct01368471- Content hash
4c8d3ce620acd334e8f2f7e66ada36ca380a1e6c1f65c8d45352a222124cfd50